EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, VolitionRX's enterprise value is $46.68 Mil.
VolitionRX's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.78 Mil. Therefore, VolitionRX's EV-to-Revenue for today is 60.23.
The historical rank and industry rank for VolitionRX's EV-to-Revenue or its related term are showing as below:
VNRX'
s EV-to-Revenue Range Over the Past 10 Years
Min: -6727.39 Med: -780.34 Max: 4347
Current: 60.23
During the past 13 years, the highest EV-to-Revenue of VolitionRX was 4347.00. The lowest was -6727.39. And the median was -780.34.
VNRX's EV-to-Revenue is ranked worse than 92.83% of 223
companies
in the Medical Diagnostics & Research industry
Industry Median: 3.26
vs VNRX: 60.23
As of today (2024-05-16), VolitionRX's stock price is $0.7869.
VolitionRX's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.01. Therefore, VolitionRX's PS Ratio for today is 78.69.
VolitionRX EV-to-Revenue Historical Data
The historical data trend for VolitionRX's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of VolitionRX's EV-to-Revenue
For the Diagnostics & Research subindustry, VolitionRX's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VolitionRX's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, VolitionRX's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where VolitionRX's EV-to-Revenue falls into.
VolitionRX's current Enterprise Value is $46.68 Mil.
VolitionRX's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.78 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VolitionRX's share price for today is $0.7869.
VolitionRX's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VolitionRX EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of VolitionRX's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
VolitionRX Ltd is a United states based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VNRX has been successfully added to your 